BAAR, Switzerland and MOUNTAIN VIEW, Calif -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced ...
FLAGSTAFF, Ariz.- W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration's (FDA's) premarket approval (PMA) of the GORE® CARDIOFORM ASD Occluder for the percutaneous closure of ...
Figure 1 - With fluoroscopic and echocardiographic guidance, the cardiologist inserts the device through the hole in the septum. The device is then partially deployed. As it is deployed from the ...
Please provide your email address to receive an email when new articles are posted on . W.L. Gore and Associates announced its occluder device was approved by the FDA for percutaneous closure of ...
W.L. Gore is bringing its Cardioform ASD Occluder to Europe. The Flagstaff, AZ-based company announced Wednesday it received CE mark for the device, which can close atrial defects (ASDs). The device ...
BAAR, Switzerland and SANTA CLARA, Calif., Feb. 8, 2022 /PRNewswire/ -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal ...
Monika Komar, Piotr Podolec, Tadeusz Przewłocki, Marta Hlawaty, Wojciech Płazak, Elżbieta Suchoń, Lidia Tomkiewicz-Pająk, Piotr Wilkołek, Wiesława Tracz ...
Atrial septal defect (ASD) is a hole in the wall between the heart’s two upper chambers. ASD is a congenital heart defect, meaning it is present from birth. In some cases of ASD, a small hole may only ...
An atrial septal defect is the persistence of a hole (the foramen ovale) in the wall (septum) between the right atrium and left atrium of the heart. The foramen ovale usually closes spontaneously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results